AAAAAA
Results: 26-50/58
Authors:
LECRUBIER Y
Citation: Y. Lecrubier, PHARMACOLOGICAL INTERVENTIONS IN DYSTHYMIA, European psychiatry, 11, 1996, pp. 129-133
Authors:
BOYER P
LECRUBIER Y
Citation: P. Boyer et Y. Lecrubier, ATYPICAL ANTIPSYCHOTIC-DRUGS IN DYSTHYMIA - PLACEBO-CONTROLLED STUDIES OF AMISULPRIDE VERSUS IMIPRAMINE, VERSUS AMINEPTINE, European psychiatry, 11, 1996, pp. 135-140
Authors:
USTUN TB
PRIVETT M
LECRUBIER Y
WEILLER E
SIMON G
KORTEN A
BASSETT SS
MAIER W
SARTORIUS N
Citation: Tb. Ustun et al., FORM, FREQUENCY AND BURDEN OF SLEEP PROBLEMS IN GENERAL HEALTH-CARE -A REPORT FROM THE WHO COLLABORATIVE STUDY ON PSYCHOLOGICAL-PROBLEMS IN GENERAL HEALTH-CARE, European psychiatry, 11, 1996, pp. 5-10
Authors:
LECRUBIER Y
WEILLER E
PRIVETT M
BOYER P
MAIER W
USTUN TB
SARTORIUS N
Citation: Y. Lecrubier et al., RECOGNITION AND TREATMENT OF PATIENTS WITH SLEEP PROBLEMS IN GENERAL HEALTH-CARE, European psychiatry, 11, 1996, pp. 11-14
Authors:
NEUMAN E
RANCUREL G
LECRUBIER Y
FOHANNO D
BOLLER F
Citation: E. Neuman et al., SCHIZOPHRENIFORM CATATONIA ON 6 CASES SECONDARY TO HYDROCEPHALUS WITHSUBTHALAMIC MESENCEPHALIC TUMOR-ASSOCIATED WITH HYPODOPAMINERGIA, Neuropsychobiology, 34(2), 1996, pp. 76-81
Authors:
LECRUBIER Y
PLETAN Y
SOLLES A
TOURNOUX A
MAGNE V
Citation: Y. Lecrubier et al., CLINICAL EFFICACY OF MILNACIPRAN - PLACEBO-CONTROLLED TRIALS, International clinical psychopharmacology, 11, 1996, pp. 29-33
Authors:
GLICK ID
LECRUBIER Y
MONTGOMERY SA
VINAR O
KLEIN DF
Citation: Id. Glick et al., EFFICACIOUS AND SAFE PSYCHOTROPICS NOT AVAILABLE IN THE UNITED-STATES, Psychiatric annals, 26(6), 1996, pp. 354-361
Authors:
WEILLER E
LECRUBIER Y
BOYER P
Citation: E. Weiller et al., ANTIDEPRESSANT USE IN GENERAL-PRACTICE, Therapie, 51(4), 1996, pp. 429-430
Authors:
SARTORIUS N
USTUN TB
LECRUBIER Y
WITTCHEN HU
Citation: N. Sartorius et al., DEPRESSION COMORBID WITH ANXIETY - RESULTS FROM THE WHO STUDY ON PSYCHOLOGICAL DISORDERS IN PRIMARY HEALTH-CARE, British Journal of Psychiatry, 168, 1996, pp. 38-43
Authors:
WEILLER E
BISSERBE JC
BOYER P
LEPINE JP
LECRUBIER Y
Citation: E. Weiller et al., SOCIAL PHOBIA IN GENERAL HEALTH-CARE - AN UNRECOGNIZED UNDERTREATED DISABLING DISORDER, British Journal of Psychiatry, 168(2), 1996, pp. 169-174
Authors:
WEILLER E
BISSERBE C
BOYER P
LEPINE JP
LECRUBIER Y
Citation: E. Weiller et al., SOCIAL PHOBIA IN GENERAL HEALTH-CARE - AN UNRECOGNIZED UNDERTREATED DISABLING DISORDER, British Journal of Psychiatry, 168, 1996, pp. 169-174
Authors:
LECRUBIER Y
BRACONNIER A
SAID S
PAYAN C
Citation: Y. Lecrubier et al., THE IMPULSIVITY RATING-SCALE (IRS) - PRELIMINARY-RESULTS, European psychiatry, 10(7), 1995, pp. 331-338
Authors:
GLICK ID
LECRUBIER Y
MONTGOMERY S
VINAR O
KLEIN DF
Citation: Id. Glick et al., PROMISING PSYCHOPHARMACOLOGICAL MEDICATIONS NOT AVAILABLE IN THE USA, Schizophrenia research, 15(1-2), 1995, pp. 151-151
Authors:
LECRUBIER Y
Citation: Y. Lecrubier, CLINICAL UTILITY OF VENLAFAXINE IN COMPARISON WITH OTHER ANTIDEPRESSANTS, International clinical psychopharmacology, 10, 1995, pp. 29-35
Authors:
LEPINE JP
PELISSOLO A
WEILLER E
BOYER P
LECRUBIER Y
Citation: Jp. Lepine et al., RECURRENT BRIEF DEPRESSION - CLINICAL AND EPIDEMIOLOGIC ISSUES, Psychopathology, 28, 1995, pp. 86-94
Authors:
BERLIN I
SAID S
SPREUXVAROQUAUX O
LAUNAY JM
OLIVARES R
MILLET V
LECRUBIER Y
PUECH AJ
Citation: I. Berlin et al., A REVERSIBLE MONOAMINE-OXIDASE-A INHIBITOR (MOCLOBEMIDE) FACILITATES SMOKING CESSATION AND ABSTINENCE IN HEAVY, DEPENDENT SMOKERS, Clinical pharmacology and therapeutics, 58(4), 1995, pp. 444-452
Authors:
BOYER P
LECRUBIER Y
PUECH AJ
DEWAILLY J
AUBIN F
Citation: P. Boyer et al., TREATMENT OF NEGATIVE SYMPTOMS IN SCHIZOPHRENIA WITH AMISULPRIDE, British Journal of Psychiatry, 166, 1995, pp. 68-72
Authors:
LECRUBIER Y
Citation: Y. Lecrubier, CHARCOT,JEAN,MARTIN, 1825-1893, The American journal of psychiatry, 152(1), 1995, pp. 121-121
Authors:
PAILLEREMARTINOT ML
LECRUBIER Y
MARTINOT JL
AUBIN F
Citation: Ml. Pailleremartinot et al., IMPROVEMENT OF SOME SCHIZOPHRENIC DEFICIT SYMPTOMS WITH LOW-DOSES OF AMISULPRIDE, The American journal of psychiatry, 152(1), 1995, pp. 130-133
Authors:
LECRUBIER Y
PEDARRIOSSE AM
PAYAN C
SCHMIDBURGK W
STABL M
Citation: Y. Lecrubier et al., MOCLOBEMIDE VERSUS CLOMIPRAMINE IN NONMELANCHOLIC, NONPSYCHOTIC MAJORDEPRESSION, Acta psychiatrica Scandinavica, 92(4), 1995, pp. 260-265
Authors:
MOLLER HJ
VANPRAAG HM
AUFDEMBRINKE B
BAILEY P
BARNES TRE
BECK J
BENTSEN H
EICH FX
FARROW L
FLEISCHHACKER WW
GERLACH J
GRAFFORD K
HENTSCHEL B
HERTKORN A
HEYLEN S
LECRUBIER Y
LEONARD JP
MCKENNA P
MAIER W
PEDERSEN V
RAPPARD A
REIN W
RYAN J
NIELSEN MS
STIEGLITZ RD
WEGENER G
WILSON J
Citation: Hj. Moller et al., NEGATIVE SYMPTOMS IN SCHIZOPHRENIA - CONSIDERATIONS FOR CLINICAL-TRIALS, Psychopharmacology, 115(1-2), 1994, pp. 221-228
Authors:
WEILLER E
BOYER P
LEPINE JP
LECRUBIER Y
Citation: E. Weiller et al., PREVALENCE OF RECURRENT BRIEF DEPRESSION IN PRIMARY-CARE, European archives of psychiatry and clinical neuroscience, 244(4), 1994, pp. 174-181
Authors:
WEILLER E
LECRUBIER Y
MAIER W
USTUN TB
Citation: E. Weiller et al., THE RELEVANCE OF RECURRENT BRIEF DEPRESSION IN PRIMARY-CARE - A REPORT FROM THE WHO PROJECT ON PSYCHOLOGICAL-PROBLEMS IN GENERAL HEALTH-CARE CONDUCTED IN 14 COUNTRIES, European archives of psychiatry and clinical neuroscience, 244(4), 1994, pp. 182-189
Authors:
LECRUBIER Y
Citation: Y. Lecrubier, FROM SERENDIPITY TO SELECTIVITY, Human psychopharmacology, 9, 1994, pp. 190000003-190000006
Authors:
MONTGOMERY S
BEAUMONT G
FEIGHNER JP
FARMER R
HENRY J
LECRUBIER Y
DALY R
LEONARD B
Citation: S. Montgomery et al., ANTIDEPRESSANT AND OVERDOSE TOXICITY - PANEL DISCUSSION, Human psychopharmacology, 9, 1994, pp. 190000041-190000046